HomeCompareIMRNW vs EQR

IMRNW vs EQR: Dividend Comparison 2026

IMRNW yields 2339.18% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IMRNW wins by $43075570633.31M in total portfolio value
10 years
IMRNW
IMRNW
● Live price
2339.18%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43075570633.35M
Annual income
$39,734,102,642,272,360.00
Full IMRNW calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — IMRNW vs EQR

📍 IMRNW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMRNWEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMRNW + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IMRNW pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMRNW
Annual income on $10K today (after 15% tax)
$198,830.41/yr
After 10yr DRIP, annual income (after tax)
$33,773,987,245,931,504.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, IMRNW beats the other by $33,773,987,245,926,850.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMRNW + EQR for your $10,000?

IMRNW: 50%EQR: 50%
100% EQR50/50100% IMRNW
Portfolio after 10yr
$21537785316.70M
Annual income
$19,867,051,321,138,916.00/yr
Blended yield
92.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

IMRNW
No analyst data
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMRNW buys
0
EQR buys
14
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$EQR▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$EQR▲ Buy$1,001 - $15,0002025-08-26
Ritchie Torres🏢 House$EQR▼ Sell$1,001 - $15,0002025-07-11
Dan Newhouse🏢 House$EQR▼ Sell$1,001 - $15,0002025-04-11
Ritchie Torres🏢 House$EQR▲ Buy$1,001 - $15,0002024-09-26
Ro Khanna🏢 House$EQR▲ Buy$1,001 - $15,0002023-10-31
Daniel Goldman🏢 House$EQR▼ Sell$50,001 - $100,0002023-07-12
Dan Newhouse🏢 House$EQR▲ Buy$1,001 - $15,0002023-04-26
Ro Khanna🏢 House$EQR▲ Buy$1,001 - $15,0002023-03-24
Ro Khanna🏢 House$EQR▼ Sell$1,001 - $15,0002023-03-14
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMRNWEQR
Forward yield2339.18%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$43075570633.35M$47.8K
Annual income after 10y$39,734,102,642,272,360.00$5,475.61
Total dividends collected$42841070616.16M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: IMRNW vs EQR ($10,000, DRIP)

YearIMRNW PortfolioIMRNW Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$244,618$233,918.13$11,380$679.82+$233.2KIMRNW
2$5,609,462$5,347,721.02$13,014$837.25+$5.60MIMRNW
3$120,610,820$114,608,695.17$14,961$1,036.20+$120.60MIMRNW
4$2,432,079,455$2,303,025,877.36$17,297$1,289.22+$2432.06MIMRNW
5$46,004,003,878$43,401,678,861.20$20,121$1,613.15+$46003.98MIMRNW
6$816,480,868,143$767,256,583,993.93$23,561$2,030.84+$816480.84MIMRNW
7$13,600,083,122,647$12,726,448,593,733.79$27,783$2,573.54+$13600083.09MIMRNW
8$212,667,837,578,363$198,115,748,637,130.90$33,013$3,284.39+$212667837.55MIMRNW
9$3,122,867,281,384,664$2,895,312,695,175,815.50$39,547$4,223.51+$3122867281.35MIMRNW
10$43,075,570,633,353,950$39,734,102,642,272,360.00$47,791$5,475.61+$43075570633.31MIMRNW

IMRNW vs EQR: Complete Analysis 2026

IMRNWStock

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers’ diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for support digestive health and gastrointestinal tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) to reduce the risk of contracting travelers’ diarrhea in the United States, and Travelers’ Diarrhea; and IMM-529, for treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

Full IMRNW Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this IMRNW vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMRNW vs SCHDIMRNW vs JEPIIMRNW vs OIMRNW vs KOIMRNW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.